Literature DB >> 28488964

Passive haemovigilance of blood components treated with a riboflavin-based pathogen reduction technology.

Dariusz Piotrowski1, Zofia Przybylska-Baluta1, Teresa Jimenez-Marco2, Lina Kryzauskaite3, Andreas Papachronis4, Aliki Marinaki4, Paul Höcker5, Sigrid Cherrier-de Wilde6, Marcia Cardoso7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28488964      PMCID： PMC6034776          DOI： 10.2450/2017.0268-16

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  7 in total

Review 1.  Haemovigilance: an effective tool for improving transfusion practice.

Authors:  R R P de Vries; J-C Faber; P F W Strengers
Journal:  Vox Sang       Date:  2011-01       Impact factor: 2.144

2.  Detection of septic transfusion reactions to platelet transfusions by active and passive surveillance.

Authors:  Hong Hong; Wenbin Xiao; Hillard M Lazarus; Caryn E Good; Robert W Maitta; Michael R Jacobs
Journal:  Blood       Date:  2015-11-23       Impact factor: 22.113

3.  Pathogen inactivation: making decisions about new technologies. Report of a consensus conference.

Authors:  Harvey G Klein; David Anderson; Marie-Josée Bernardi; Ritchard Cable; William Carey; Jeffrey S Hoch; Nancy Robitaille; Marco L A Sivilotti; Fiona Smaill
Journal:  Transfusion       Date:  2007-12       Impact factor: 3.157

4.  A comparison of adverse reaction rates for PAS C versus plasma platelet units.

Authors:  Claudia S Cohn; James Stubbs; Joseph Schwartz; Richard Francis; Cheryl Goss; Melissa Cushing; Beth Shaz; David Mair; Barbara Brantigan; W Andrew Heaton
Journal:  Transfusion       Date:  2014-04-16       Impact factor: 3.157

Review 5.  Chemical and biological mechanisms of pathogen reduction technologies.

Authors:  Janna M Mundt; Lindsay Rouse; Jeroen Van den Bossche; Raymond P Goodrich
Journal:  Photochem Photobiol       Date:  2014-08-20       Impact factor: 3.421

6.  A prospective, active haemovigilance study with combined cohort analysis of 19,175 transfusions of platelet components prepared with amotosalen-UVA photochemical treatment.

Authors:  F Knutson; J Osselaer; L Pierelli; M Lozano; J Cid; R Tardivel; O Garraud; T Hervig; D Domanovic; M Cukjati; S Gudmundson; I B Hjalmarsdottir; A Castrillo; R Gonzalez; D Brihante; M Santos; P Schlenke; A Elliott; J-S Lin; D Tappe; A Stassinopoulos; J Green; L Corash
Journal:  Vox Sang       Date:  2015-05-15       Impact factor: 2.144

7.  Hemovigilance and blood safety.

Authors:  Ashish Jain; Ravneet Kaur
Journal:  Asian J Transfus Sci       Date:  2012-07
  7 in total
  3 in total

1.  Pathogen reduction of blood components during outbreaks of infectious diseases in the European Union: an expert opinion from the European Centre for Disease Prevention and Control consultation meeting.

Authors:  Dragoslav Domanović; Ines Ushiro-Lumb; Veerle Compernolle; Sergio Brusin; Markus Funk; Pierre Gallian; Jørgen Georgsen; Mart Janssen; Teresa Jimenez-Marco; Folke Knutson; Giancarlo M Liumbruno; Polonca Mali; Giuseppe Marano; Yuyun Maryuningsih; Christoph Niederhauser; Constantina Politis; Simonetta Pupella; Guy Rautmann; Karmin Saadat; Imad Sandid; Ana P Sousa; Stefania Vaglio; Claudio Velati; Nicole Verdun; Miguel Vesga; Paolo Rebulla
Journal:  Blood Transfus       Date:  2019-12-11       Impact factor: 3.443

2.  Haemostatic function measured by thromboelastography and metabolic activity of platelets treated with riboflavin and UV light.

Authors:  Carme Ballester-Servera; Teresa Jimenez-Marco; Daniel Morell-Garcia; Miguel Quetglas-Oliver; Antonia M Bautista-Gili; Enrique Girona-Llobera
Journal:  Blood Transfus       Date:  2020-05-15       Impact factor: 3.443

Review 3.  Contemporary resuscitation of hemorrhagic shock: What will the future hold?

Authors:  Amanda M Chipman; Carleigh Jenne; Feng Wu; Rosemary A Kozar
Journal:  Am J Surg       Date:  2020-05-11       Impact factor: 2.565
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.